Lobbying client
NISIBIS LLC
Bone Marrow Research
Filings
22
Filed by
1
Reported in-house
—
Reported by firms
$10,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2020 to 2025
Filings
22 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination (No Activity) 3rd Quarter 2025
|
ALBERTINE ENTERPRISES, INC. | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2025
|
ALBERTINE ENTERPRISES, INC. | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2025
|
ALBERTINE ENTERPRISES, INC. | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2024
|
ALBERTINE ENTERPRISES, INC. | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2024
|
ALBERTINE ENTERPRISES, INC. | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2024
|
ALBERTINE ENTERPRISES, INC. | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2024
|
ALBERTINE ENTERPRISES, INC. | — reported |
|
4th Quarter - Report (No Activity) 4th Quarter 2023
|
ALBERTINE ENTERPRISES, INC. | — reported |
|
3rd Quarter - Report (No Activity) 3rd Quarter 2023
|
ALBERTINE ENTERPRISES, INC. | — reported |
|
2nd Quarter - Report (No Activity) 2nd Quarter 2023
|
ALBERTINE ENTERPRISES, INC. | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| ALBERTINE ENTERPRISES, INC. | 21 | $10,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 1 |
| Medical/Disease Research/Clinical Labs | MED | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.